ImmunoScape Announces Three Presentations Highlighting TCR Pipeline and Discovery Platform at the American Association for Cancer Research (AACR) Annual Meeting 2024
ImmunoScape, a biotechnology company focused on next-generation T Cell receptor (TCR)-based immunotherapies, today announced that three…